Results 31 to 40 of about 30,694,151 (287)

Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease

open access: yesFrontiers in Neurology, 2018
L-DOPA is still the most effective pharmacological therapy for the treatment of motor symptoms in Parkinson's disease (PD) almost four decades after it was first used.
M. Muthuraman   +7 more
semanticscholar   +1 more source

Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease

open access: yesNeurobiology of Disease, 2010
Benefit and motor side effects of l-DOPA in Parkinson's disease have been related to dopamine transmission in the striatum. However, the putative involvement of serotonergic neurons in the dopaminergic effects of l-DOPA suggests that the striatum is not ...
Sylvia Navailles   +3 more
doaj   +1 more source

Cost-Effective Production of L-DOPA by Tyrosinase-Immobilized Polyhydroxyalkanoate Nanogranules in Engineered Halomonas bluephagenesis TD01

open access: yesMolecules, 2021
3,4-dihydroxyphenyl-L-alanine (L-DOPA) is a preferred drug for Parkinson’s disease, with an increasing demand worldwide that mainly relies on costly and environmentally problematic chemical synthesis.
Jiping Zhao   +4 more
doaj   +1 more source

Altered resting state cortico-striatal connectivity in mild to moderate stage Parkinson’s disease

open access: yesFrontiers in Systems Neuroscience, 2010
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that is characterized by dopamine depletion in the striatum. One consistent pathophysiological hallmark of PD is an increase in spontaneous oscillatory activity in the basal ganglia ...
Youngbin Kwak   +9 more
doaj   +1 more source

Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure. [PDF]

open access: yesPLoS ONE, 2008
L-3,4-dihydroxypheylalanine (L-dopa)-induced dyskinesia represent a debilitating complication of therapy for Parkinson's disease (PD) that result from a progressive sensitization through repeated L-dopa exposures. The MPTP macaque model was used to study
Birger Scholz   +11 more
doaj   +1 more source

Technological prospection: patents mapping involving compounds for the treatment of L-DOPA-induced dyskinesias

open access: yes, 2019
Introduction: Parkinson’s disease (PD), is a disorder debilitant characterized by the reduction of nigrostriatal dopaminergic neurons within the midbrain, specifically in the substantia nigra pars compacta, which results for the dopamine (DA) depletion ...
Lorenna Emília Sena Lopes (7860332)   +3 more
core   +1 more source

Designing Silver Nanoparticles for Detecting Levodopa (3,4-Dihydroxyphenylalanine, L-Dopa) Using Surface-Enhanced Raman Scattering (SERS)

open access: yesItalian National Conference on Sensors, 2019
Detection of the drug Levodopa (3,4-dihydroxyphenylalanine, L-Dopa) is essential for the medical treatment of several neural disorders, including Parkinson’s disease.
R. Rubira   +8 more
semanticscholar   +1 more source

Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys. [PDF]

open access: yesPLoS ONE, 2010
BackgroundRadiotracer imaging of the presynaptic nigrostriatal dopaminergic system is used to assess disease progression in Parkinson's disease (PD) and may provide a useful adjunct to clinical assessment during therapeutic trials of potential ...
Pierre-Olivier Fernagut   +8 more
doaj   +1 more source

L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia

open access: yesCerebral Cortex, 2016
Dopamine depletion in Parkinson's disease (PD) produces dendritic spine loss in striatal medium spiny neurons (MSNs) and increases their excitability. However, the synaptic changes that occur in MSNs in PD, in particular those induced by chronic L-3,4 ...
L. M. Suarez   +4 more
semanticscholar   +1 more source

Pramipexole in comparison to l-dopa: a neuropsychological study

open access: yes, 2003
Twenty right-handed patients affected by early/mild Parkinson's disease were evaluated in a randomised study using neuropsychological and clinical assessements during three treatment modalities: when in the off treatment condition, when on pramipexole ...
Peppe, A   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy